Literature DB >> 25036714

Radiation and ATM inhibition: the heart of the matter.

Ester M Hammond, Ruth J Muschel.   

Abstract

Numerous in vitro studies have shown that human cell lines lacking functional ATM are extremely radiosensitive. In this issue, Moding et al. demonstrate using a murine model of sarcoma that deletion of the Atm gene has much less of a radiosensitizing effect on normal cardiac endothelia than on rapidly proliferating tumor endothelia. This work confounds our assumptions about the generality of the role of ATM in radiation sensitivity and the potential use of ATM inhibitors as radiosensitizers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25036714      PMCID: PMC4109529          DOI: 10.1172/JCI77195

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.

Authors:  Ian Hickson; Yan Zhao; Caroline J Richardson; Sharon J Green; Niall M B Martin; Alisdair I Orr; Philip M Reaper; Stephen P Jackson; Nicola J Curtin; Graeme C M Smith
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

2.  The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.

Authors:  Geoff Delaney; Susannah Jacob; Carolyn Featherstone; Michael Barton
Journal:  Cancer       Date:  2005-09-15       Impact factor: 6.860

Review 3.  The DNA-damage response in human biology and disease.

Authors:  Stephen P Jackson; Jiri Bartek
Journal:  Nature       Date:  2009-10-22       Impact factor: 49.962

Review 4.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.

Authors:  Yosef Shiloh; Yael Ziv
Journal:  Nat Rev Mol Cell Biol       Date:  2013-03-13       Impact factor: 94.444

5.  ATM activation in the presence of oxidative stress.

Authors:  Zhi Guo; Rajashree Deshpande; Tanya T Paull
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

6.  Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium.

Authors:  Everett J Moding; Chang-Lung Lee; Katherine D Castle; Patrick Oh; Lan Mao; Shan Zha; Hooney D Min; Yan Ma; Shiva Das; David G Kirsch
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

7.  A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity.

Authors:  Martin Kühne; Enriqueta Riballo; Nicole Rief; Kai Rothkamm; Penny A Jeggo; Markus Löbrich
Journal:  Cancer Res       Date:  2004-01-15       Impact factor: 12.701

8.  ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin.

Authors:  Aaron A Goodarzi; Angela T Noon; Dorothee Deckbar; Yael Ziv; Yosef Shiloh; Markus Löbrich; Penny A Jeggo
Journal:  Mol Cell       Date:  2008-07-25       Impact factor: 17.970

9.  ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

Authors:  Shuhei Matsuoka; Bryan A Ballif; Agata Smogorzewska; E Robert McDonald; Kristen E Hurov; Ji Luo; Corey E Bakalarski; Zhenming Zhao; Nicole Solimini; Yaniv Lerenthal; Yosef Shiloh; Steven P Gygi; Stephen J Elledge
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

10.  Replication stress and chromatin context link ATM activation to a role in DNA replication.

Authors:  Monica M Olcina; Iosifina P Foskolou; Selvakumar Anbalagan; Joana M Senra; Isabel M Pires; Yanyan Jiang; Anderson J Ryan; Ester M Hammond
Journal:  Mol Cell       Date:  2013-11-21       Impact factor: 17.970

View more
  9 in total

1.  Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.

Authors:  Lorna Rodriguez-Rodriguez; Kim M Hirshfield; Veronica Rojas; Robert S DiPaola; Darlene Gibbon; Mira Hellmann; Sara Isani; Aliza Leiser; Gregory M Riedlinger; Allison Wagreich; Siraj M Ali; Julia A Elvin; Vincent A Miller; Shridar Ganesan
Journal:  Gynecol Oncol       Date:  2016-04       Impact factor: 5.482

2.  Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study.

Authors:  Aurelija Jucaite; Per Stenkrona; Zsolt Cselényi; Serena De Vita; Nuria Buil-Bruna; Katarina Varnäs; Alicia Savage; Andrea Varrone; Peter Johnström; Magnus Schou; Chris Davison; Andy Sykes; Venkatesh Pilla Reddy; Matthias Hoch; Ana Vazquez-Romero; Mohammad Mahdi Moein; Christer Halldin; Melinda S Merchant; Martin Pass; Lars Farde
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

Review 3.  Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids.

Authors:  Stephen Riffle; Rashmi S Hegde
Journal:  J Exp Clin Cancer Res       Date:  2017-08-03

Review 4.  The role of the ataxia telangiectasia mutated gene in lung cancer: recent advances in research.

Authors:  Yanling Xu; Peng Gao; Xuejiao Lv; Lin Zhang; Jie Zhang
Journal:  Ther Adv Respir Dis       Date:  2017-08-21       Impact factor: 4.031

Review 5.  Current and Future Perspectives of the Use of Organoids in Radiobiology.

Authors:  Peter W Nagle; Robert P Coppes
Journal:  Cells       Date:  2020-12-09       Impact factor: 6.600

6.  Exploring the differentially expressed genes in human lymphocytes upon response to ionizing radiation: a network biology approach.

Authors:  Tamizh Selvan Gnana Sekaran; Vishakh R Kedilaya; Suchetha N Kumari; Praveenkumar Shetty; Pavan Gollapalli
Journal:  Radiat Oncol J       Date:  2021-03-24

Review 7.  Therapeutic strategies of different HPV status in Head and Neck Squamous Cell Carcinoma.

Authors:  Yingming Sun; Zhe Wang; Sufang Qiu; Ruoyu Wang
Journal:  Int J Biol Sci       Date:  2021-03-10       Impact factor: 6.580

8.  Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic.

Authors:  Yuewen Zhang; Lei Wu; Zhao Wang; Jinpeng Wang; Shrabasti Roychoudhury; Bartlomiej Tomasik; Gang Wu; Geng Wang; Xinrui Rao; Rui Zhou
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

9.  Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma.

Authors:  Xinjian Yan; Tianyu Wu; Mei Tang; Dongliang Chen; Meiyuan Huang; Sichun Zhou; Huihui Zhang; Xiaoping Yang; Gaofeng Li
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.